BOSTON SCIENTIFIC CORP cotiza a 43.31 USD y tiene una capitalización bursátil de $62.8B. En los últimos 12 meses ha facturado $21.0B con un margen de flujo de caja libre del 18.2%. Cotiza a 17.3 veces su flujo de caja libre (P/FCF) y a un PER de 17.1. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, b…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.86 | $0.80 | $0.80 |
| Estimado | $0.75 | $0.83 | $0.79 | $0.78 |
| Sorpresa | — | +3.6% | +1.3% | +2.6% |
| Métrica | BSX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 69.0% | 57.0% | +12.0% |
| Operating Margin | 18.0% | -38.6% | +56.6% |
| Net Margin | 14.4% | -33.6% | +48.0% |
| FCF Margin | 18.2% | -13.9% | +32.1% |
| ROE | 12.0% | -40.4% | +52.4% |
| ROA | 6.6% | -32.0% | +38.6% |
| Current Ratio | 1.62 | 2.84 | -1.22 |
| Debt / Equity | 0.46 | 0.28 | +0.18 |